The use of semaglutide in combination with other investigational agents, including amylin analogues (cagrilintide in the CagriSema combination program), sodium-glucose cotransporter-2 (SGLT-2) inhibitors, and long-acting insulin analogues, creates additional API demand multipliers across the clinical pipeline
The computational analysis of this work was performed in part with the support of the supercomputer system of the National Institute of Genetics (NIG), Research Organization of Information and Systems (ROIS)
Get the details and learn which floss and pick products are our Top Picks
Injecting any substance into the body carries inherent risks, including the potential for allergic reactions, infections, and other adverse effects
The Surprising Link Between Muscle Mass and Metabolic Health Can Muscle Loss Impact Metabolic Health
High-throughput capillary electrophoretic method for determination of total aminothiols in plasma and urine